Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Jönköping – page 4

45 clinical trials in Jönköping, Sweden across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Jönköping at a glance
45
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

45 trials in Jönköping

Open in trial search

Facial paresis

Not recruiting

Study on Betamethasone Sodium Phosphate for Treating Acute Facial Nerve Palsy in Children

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Sponsor:Region Dalarna

Breast cancer

Not recruiting

Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane

Bladder cancer+2

Not recruiting

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Malignant melanoma

Not recruiting

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Study on Dexamethasone Eye Drops for Infants with Retinopathy of Prematurity

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Dexamethasone Phosphate
  • Sponsor:Vaestra Goetalandsregionen

Study comparing trifluridine/tipiracil with bevacizumab versus capecitabine with bevacizumab as first-line treatment for patients with metastatic colorectal cancer who cannot receive intensive therapy

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Ixekizumab
  • Sponsor:NU Hospital Group-Vaestra Goetalandsregionen

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Gilead Sciences Inc.

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Jönköping

What the registry says about research in the country

01 Oncology Research

Comprehensive studies focusing on breast cancer treatments, including innovative therapies for triple-negative and HER2-positive variants. Research also encompasses pediatric cancer and novel approaches for testicular cancer treatment.

  • Advanced metastatic breast cancer therapies
  • Pediatric cancer immunization studies
  • Prostate cancer biomarker research

These trials aim to improve treatment outcomes and patient survival rates through targeted therapies and personalized treatment approaches.

02 Cardiovascular Studies

Innovative research in heart failure management, particularly focusing on preserved ejection fraction conditions. Studies evaluate new drug combinations and treatment strategies.

  • Heart failure treatment optimization
  • Dyslipidemia management
  • Cardiovascular risk reduction

Clinical trials aim to enhance cardiac care through medication optimization and novel therapeutic approaches.

03 Immunology and Infectious Diseases

Research examining HPV infection prevention and treatment strategies, along with studies on tonsillitis management and antibiotic effectiveness.

  • Vaccination effectiveness studies
  • Antibiotic treatment protocols
  • Infection prevention strategies

Trials focus on developing improved prevention methods and treatment protocols for various infectious conditions.

04 Endocrinology Research

Studies investigating treatments for Type 1 and Type 2 diabetes, exploring new therapeutic approaches and medication effectiveness.

  • Diabetes management innovations
  • Beta cell preservation studies
  • Comparative treatment trials

Research aims to improve diabetes care through innovative treatment strategies and therapeutic interventions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.